Introduction: The wholesale FOXO4 DRI peptide selectively induces apoptosis in senescent cells by disrupting FOXO4-p53 binding, offering stable, superior-purity supplies for getting older and cancer study. Daily laboratory workflows normally expose a persistent challenge: the slow and inefficient removal of senescent cells that impair tissue funct